November’s top stories: Grifols’ $1.7bn acquistion, Sorin’s approvals

Image: Boston Scientific receives FDA approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system. Photo: courtesy of Boston Scientific Corporation.